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A growing knowledge base of genetic and environmental information has greatly enabled the study of disease
risk factors. However, the computational complexity and statistical burden of testing all variants by all environments
has required novel study designs and hypothesis-driven approaches. We discuss how incorporating biological
knowledge frommodel organisms, functional genomics, and integrative approaches can empower the discovery of
novel gene-environment interactions and discuss specific methodological considerations with each approach. We
consider specific examples where the application of these approaches has uncovered effects of gene-environment
interactions relevant to drug response and immunity, and we highlight how such improvements enable a greater
understanding of the pathogenesis of disease and the realization of precision medicine.
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Abbreviations: eQTL, expression quantitative trait locus; GWAS, genome-wide association study; G×E, gene-environment
interaction; SNP, single nucleotide polymorphism.
In the quest for the discovery of genetic and environmental risk
factors associatedwith common, complex disease risk, researchers
have largely focused on either the genome or “the exposome,” the
multitude of environmental factors affecting the individual’s
health. To identify genetic risk factors, genetics researchers have
used a variety of study design techniques, including family-based
linkage studies, candidate-gene association studies, and more
recently genome-wide association studies (GWASs). Through
unbiased, genome-wide scans, GWASs have identified thousands
of common genetic variants associated with risk for common
diseases (1), some of which highlight new biological pathways.
However, the effects of associated variants are typically small and
account for only a small proportion of the estimated heritability (2,
3). To identify environmental risk factors, epidemiologists have
applied diverse study designs ranging from observational studies
of the environment—investigating factors outside of the control of
the individual (air pollution, water contaminants, etc.)—to experi-
mental studies of modifiable risks, such as nutritional interven-
tions. Classical studies of single environmental factors, such as
radon and smoking, have greatly advanced our understanding of
health (4). However, in recent years, large-scale environmental
screening projects have emerged to enable simultaneous study
of multiple environmental factors, or the exposome. These large-
scale investigations are subject to many of the challenges of “big
data” research, including high correlation among study variables,
multiple testing corrections, andmissing data (5).
The risk of common diseases is often due to a complex inter-
play of the genome and the exposome; however, the degree
to which genetic versus environmental factors alter risk varies
greatly by disease. For example, in certain subtypes of lung can-
cer, carcinogens in tobacco smoke have such a strong influence
on disease risk that the effects of genetic variation pale in compari-
son (6). Conversely, a familial subtype of breast cancer, resulting
from mutations in BRCA1/BRCA2 genes, is predominantly ex-
plained by the genetic component of risk (7). Given that individ-
ual variability in both genes and environment can influence
771 Am J Epidemiol. 2017;186(7):771–777
disease risk, joint analysis of the genome and the exposome, as
well as their potential interactions, will provide better insights into
disease etiology. However, with tens of millions of variants and
thousands of measured environmental variables, the challenge
is identifying how to do so effectively.
Publicly funded research has provided a wealth of genetic and
environmental data. The All of Us Research Program announced
in 2015 aims to further support data-driven science by building a
national research cohort of 1 million or more US participants
with genetic and environmental data (https://www.nih.gov/
research-training/allofus-research-program). As these types of
resources grow, the challenges of big-data analysis are a sig-
nificant consideration for genomic and exposome research.
Analyzing data sets that include both types of data only exac-
erbate these issues further. GWASs have had remarkable suc-
cess in combining analyses across diverse studies to improve
power. However, for exposome studies, challenges remain in uni-
fying measurements and defining analytical procedures.When
such analyses can be achieved, several challenges emerge. These
issues include computational complexity issues, a very large
multiple-testing burden, big p small n (manymore variables than
individuals/samples), and often sparse data matrices (due tomiss-
ing data). In order to deal with these issues, many approaches
perform some form of data reduction or filtering prior to analysis
to increase statistical power to detect interactions.
One strategy for data reduction is to use genetic association
data to identify genetic risk variants that are then coupled with
epidemiologic/environmental data. This strategy depends on the
assumption that the genes influencing risk through interactions
with environmental factors will also show significant indepen-
dent/marginal association with disease. Thus, a 2-step approach
can be taken in which stage 1 is a genome-wide scan of single
nucleotide polymorphism (SNP) associations to identify a smal-
ler set of SNPs passing a P value threshold to carry forward. In
stage 2, the prioritized variant list is tested for SNP-environment
interaction with the available environmental factors (8). This
makes an important assumption about the relevance of the
marginal SNP effect, but this strategy can be quite powerful
when that assumption ismet. Note that for quantitative outcomes,
other criteria have been proposed to filter SNPs at step 1, includ-
ing, for example, a test of heterogeneity of variance by genotypic
classes (9).
Another approach to improving the power of interaction stud-
ies is to test for association with underlying quantitative traits for
diseases that have a clear genetic component, referred to as en-
dophenotypes. In some situations, such endophenotypes may be
better measured and representative of the mechanistic pathway
toward disease risk. For example, lipid profiles or glucose toler-
ance tests may be more appropriate for certain genetic associa-
tion tests because they are closer to gene action than the disease
outcome of heart disease or diabetes (10). Much like using mar-
ginal SNP association tests for selecting SNPs, by using endo-
phenotypes that are closer to the molecular function of the gene,
we will have more power to filter for potentially functional
SNPs in subsequent gene-environment interaction (G×E) analy-
ses. As we will discuss below, molecular endophenotypes such
as gene expression may have sufficient power to filter environ-
mental factors as well.
Finally, some studies have begun using prior biological
knowledge to reduce the genome down to a set of candidate
genes for G×E analyses. Here, there are a number of strate-
gies for gene selection, each based on a set of assumptions:
• Evidence in the literature for variants in the gene region asso-
ciated with the disease of interest
• Evidence in the literature of the gene associated with envi-
ronmental factors of interest
• Genes related to the pathways where environmental factors
may play a role
• Variants that are positioned in functional regions of the
genome
• Use of public databases of G×E relationships and informa-
tion about regulatory regions of the genome to filter the can-
didate genes and environmental factors
This is just a short list of options to reduce the genome to a smal-
ler list of genes to test for G×Es. Such options are complemented
by the use of model organism studies, which have several advan-
tages for analyzing G×Es because environmental exposures can
be carefully controlled and the genetic structure of the study can
be leveraged to improve power (discussed further in McAllister
et al. (11)). A variety of model organisms have been used for
discovering G×Es (12) including yeast (13), Drosophila (14),
and mouse (15, 16). Compared to human G×E studies, model
organism studies allow the measurement of genetically simi-
lar individuals across multiple distinct environments. Consider-
able work has been done in this area, and it is outside the scope
of this review. Thus, we focus our review on strategies that take
advantage of molecular and cellular endophenotypes and multi-
omics data.
USEOF -OMICS TO INFORMG×EDISCOVERY
Molecular and cellular endophenotypes provide a unique
opportunity to identify genetic variants responsive to the envi-
ronment at a more basic, mechanistic level. Unlike a GWAS,
which may require tens of thousands of individuals to identify
genetic variants associated with a phenotype, comparable stud-
ies of molecular and cellular endophenotypes using functional
genomics have identified abundant associations with only doz-
ens of individuals. This increased power to identify functional
genetic loci has culminated in a wide diversity of quantitative
trait studies for functional genomics data (or -omics), including
epigenomes, methylomes, proteomes, and transcriptomes. Deci-
phering the role of these functional loci across human tissues has
relied upon epigenome maps generated within large-scale pro-
jects where the data are publicly available, such as ENCODE
(17) and the NIH Epigenomics Roadmap (18), in combina-
tion with expression quantitative trait locus (eQTL) studies
from projects such as Multiple Tissue Human Expression
Resource (MuTHER) (19) and Genotype-Tissue Expression
(GTEx) (20).
Similar to using a marginal association test to prioritize impor-
tant SNPs, epigenomic data (chromatin immunoprecipitation
assays with sequencing (ChIP-seq), DNase I hypersensitive site
sequencing (DNaseI-seq), and assay for transposase-accessible
chromatin using sequencing (ATAC-seq)) can be used to identify
enhancers and other regulatory elements in the genome and,
subsequently, to prioritize variants positioned in those regions.
Therefore, a straightforward application of -omics data is to
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identify responsive elements or variants at a molecular level
in order to select candidate variants to test in G×E analyses.
In recent years, several studies have taken advantage of the
increased power of molecular studies to map G×E effects. Bar-
reiro et al. (21) mapped eQTLs in primary dendritic cells from 65
individuals before and after infection withMycobacterium tuber-
culosis and identified 198 response eQTLs specific to either con-
dition. This study demonstrated that nonnegligible numbers of
G×E effects exist in the context of an infection and that mapping
these variants and genes can be accomplished with limited num-
bers of individuals in well-controlled in vitro assays. Following
this work, multiple studies have perturbed primary blood cells to
elicit immune-response eQTLs (22–25). Beyond gene expression,
response QTLs using chromatin accessibility assays have identi-
fied that immune-response eQTLs can be foreshadowed in the
naïve state by regulatory variants influencing chromatin accessib-
ility (26). This observation provides new opportunity to identify
primed response variants that may underlie unexplained, noncod-
ing, complex trait associations (27).
Response eQTLs need not be identified through in vitro per-
turbations alone; increasingly, studies of the interaction of obser-
vational variables such as age, sex, or behavior in cohorts with
genetic and functional genomics data have identified G×E var-
iants (28–31). For age- and sex-specific eQTLs, Yao et al. (28)
focused on known complex disease-associated variants in a
cohort of 5,254 individuals where whole blood gene expression
wasmeasured. They identified 10 age-specific and 14 sex-specific
eQTLs, highlighting a notable scarcity of variants with strong ef-
fects given either variable. In addition to these variables, behaviors
such as smoking, medication use, and exercise have been studied
for G×E effects on gene expression; Knowles et al. (30) recently
surveyed these variables using a novel approach for allele-specific
expression to identify G×E effects for each environment. In both
this study and Zhernakova et al. (31), investigators adopted the
use of “proxy environments” to model unobserved perturbations,
such as an individual’s cell-type composition or infection status
in discovery of interaction effects, providing a means to test pre-
viously unmeasured environments. Furthermore, the impact of
genetics and in utero environments—including maternal smok-
ing, birth weight, and birth order—have been observed to have
large effects on an individual’smethylome at birth (32, 33).
METHODOLOGICAL ANDSTUDYDESIGN ISSUESWITH
THEUSEOF -OMICSDATA
Use of -omics data in the discovery of G×Es presents unique
methodological issues. First, there is the issue of tissue specific-
ity. The identity of the most effective tissues for interaction test-
ing is not always clear. For instance, in pursuing genetic
contributors to adverse drug reactions, we could analyze either
drug-metabolizing tissues such as the liver or the tissues where
adverse effects are presented. Obtaining these tissues can be
quite challenging, and even if samples can be obtained, we must
consider whether such effects can be more easily and less inva-
sively discovered from accessible patient tissues such as skin or
blood. Indeed, in the study of adverse drug reactions to statins,
the link to the GATM gene was observed through analysis of
statin-response eQTLs in lymphoblastoid cells rather than mus-
cle or liver (34). Determining the extent of tissue specificity of
genetic effects is still a major challenge. Studies such as the
Genotype-Tissue Expression project have begun to compre-
hensively identify tissue-shared and tissue-specific effects (20).
Designing G×E studies in the correct tissues will further benefit
from increasingly rich epigenomic maps, such as ENCODE and
the NIH Epigenomics Roadmap. By identifying the regions that
are differentially accessible in response to an environmental per-
turbation in a few tissues, one can use these large maps to gain
insight into the relative benefits of G×E testing in different tissues.
The problem of statistical power and adequate sample size
can significantly impede G×E studies (35). To study the effect
of a cellular perturbation in vitro as in the study by Fairfax et al.
(22), sample sizes of a few hundred individuals per condition or
a few time points may be required. The study design should
include -omics analysis (RNA sequencing, DNase-Seq, ATAC-
Seq, etc.) at every condition or time point. If measurements are
made on the same individuals, then statistical methods need to
account for within-person correlation, an adjustment that may
decrease power. This design is feasible for in vitro studies. Only
recently have in vivo studies begun to track large numbers of in-
dividuals with repeated -omics measurements. These emerging
studies pose additional challenges. In vivo studies need to account
for the potential impact of multiple environments, increased vari-
ability in sample collection andmeasures of the environment, and
increased challenges in causal inference.
Other methodological challenges facing G×E studies arise
largely from the inherent properties of -omics data. Data gener-
ated from a specific -omics technology are modeled better by
certain distributions than others. Knowledge of the underlying
distribution of the data governs the models chosen to detect
G×E effects. For example, it has been widely shown that gene
expression as measured by RNA sequencing can be adequately
modeled by a negative binomial distribution (36). For gene
expression measured using microarrays, one might chose a linear
model with an interaction term (gene-expression variable × envi-
ronment). However, for RNA-sequencing data, a generalized lin-
ear model accounting for overdispersion in the count data may be
preferable. Another consideration is that -omics data encounters
challenges from known and unknown confounders. Known con-
foundersmay include sex, age, or batch. In fact, known biological
confounders may appear as environmental effects that we wish to
test in a subset of our analysis. Many methods have been devel-
oped to remove these unwanted effects in the context of eQTL
studies from simple linear regression and/or principal components
analysis to more advanced techniques (probabilistic estimation
of expression residuals (37), HCP (38), svaseq (39)). For
in vitro studies, these methods are typically applied to each
condition or time point separately. For in vivo studies, one
must take care not to remove the environmental effect to be
tested. Given the diversity of cellular perturbations that can
be assayed and studied for G×E effects, an ongoing bottleneck
is selecting specific environments to assay. Moyerbrailean
et al. (40) demonstrated an effect pipeline for assessing G×E
effects across 250 environments (50 perturbations in 5 cell
types) where all perturbations were tested using low-pass
transcriptome sequencing. Only those perturbations with sig-
nificant differences were then carried forward for deeper
sequencing and assessment of context-specific, allele-specific
expression. Using this approach, they identified 215 genes
with G×Es, of which nearly 50% were implicated in previous
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GWASs, thereby providing a rich resource of candidate hypoth-
eses for further investigation.
Ultimately, estimating the degree to which genetics and envi-
ronment contribute to molecular and cellular phenotypes poses
a principal challenge to G×E study design. Multiple gene-
expression studies have used family relationships to determine
the relative contributions of genetics and environment, reporting
average heritability from 0.1 to 0.26 (41, 42). The majority of
studies calculate heritability from total expression levels, but
allele-specific expression is increasingly complementing these
estimates. Buil et al. (41) used allele-specific expression mea-
sured in a twin study of approximately 400 female twin pairs
with RNA- sequencing data from different tissues (fat, lympho-
blastoid cell lines, skin, and blood) to measure the relative con-
tribution of genetics and environment. In support of previous
studies, they found little evidence for shared environmental ef-
fects. However, they found significant evidence of unique or
individual-specific environmental effects, explaining approxi-
mately 10%–20% of expression variation in each of the tissues,
on par with cis or cis-trans effects, and they further estimated
that 38%–49%of variance observed in allele-specific expression
was not explained by additive effects and was due to gene-gene
or G×E effects. Despite this, limitations on power influenced the
discovery of specific G×E associations, highlighting that either
larger studies or candidate studies were required.
INTEGRATIVE ANDPATHWAY-BASEDSTRATEGIES
Genes do not act in isolation; they function through physical,
metabolic, and chemical reactions with other genes in large path-
ways and networks. Yet when we look for associations between
genes and disease outcomes or even G×Es, we tend to treat each
gene independently. If we embrace the complexity and relation-
ships between genes in pathways, we may increase our power to
detect and interpret our findings. Many researchers describe path-
way approaches as being antithetical to the unbiased genome-
wide perspective. Thomas (43) describesways that these powerful
pathway-based approaches can further enhance power and
insights rather than replace the GWAS approach.While taking
an agnostic GWAS approach to generate the genetic data might
be beneficial to ensure that all regions of the genome are
explored, these data can be married with hierarchical modeling
strategies that exploit pathway knowledge when we perform
analyses of genome-wide data (43).
Exploring candidate pathways and using biological knowl-
edge related to the environment in the gene selection process
can potentially be a powerful alternative to the current paradigm.
Two strategies can be applied. First, as for gene-based and
pathway-based analyses of marginal SNP effects, we can per-
form an agnostic search for enrichment of interaction effects.
Indeed, existing methods such as gene-set enrichment analysis
(44) only assume genome-wide P values of the test considered
(marginal effect, a priori) following a uniform distribution under
the null hypothesis of no enrichment. Therefore, these methods
can be directly applied to the standard 1-degree-of-freedom test of
interaction performed on a genome-wide scale. Because it relies
on established methodologies, some groups have already started
to apply such strategies. For example, Wei et al. (45) combined
gene-based testing with pathway enrichment analyses to look for
G×E associationswith lung-cancer susceptibility.
The second potential strategy is to use pathway information
to reduce the search space for interactions, as in candidate-based
approaches. To facilitate selection of candidate variants and
study of G×Es, the CardioGxE database has extensively curated
G×Evariants in the literature (46). Further, as discussed in previ-
ous sections, a common strategy in G×E screening is to assume
SNPs involved in interaction effects also display a marginal
effect. Similarly, one can argue that SNPs involved in interac-
tions might be enriched in pathways related to the outcome or
the exposure in question. Building on this idea, Rava et al. (47)
proposed a strategy to select genes for G×E for associations
with asthma (a trait for which earlier G×E studies did not find
strong evidence of associations). They selected the canonical
pathways that the set of candidate genes belong to and included
biological knowledge related to the environment in their gene
selection process. Their approach reduced the gene list to a small
and focused set for G×E analysis (47). Similar approaches have
been adopted for other diseases as well. Huang and Hu (48)
used these same strategies to look for G×Es and associations
with obesity. Tang et al. (49) performed gene-based gene ×
smoking interaction analysis, followed by enrichment analysis of
nominally interacting genes in canonical biological pathways, and
found that the axonal guidance signaling pathway interacted with
smoking to modify the risk of pancreatic cancer. Of note, exactly
the same pathway was identified to be enriched with recurrent
somatic point mutations and copy number aberrations by an
exome-sequencing study of pancreatic tumors (50). This study
also suggested a negative correlation between somatic mutations
in the axonal guidance pathway and smoking—nonsmokers were
more likely to have somatic mutations in this pathway than smo-
kers. For the first time, both GWAS and somatic mutation data
pointed to the same biological pathway that might interact with
smoking inmodifying cancer risk.
To integrate this type of biological knowledge into an analy-
sis, bioinformatics tools such as Biofilter can be used. Biofilter
is a knowledge integration tool developed to allow for annota-
tion, filtering, and model building of genomic data (51, 52). The
underlying database of biological knowledge within Biofilter is
called the Library of Knowledge Integration (LOKI) and con-
sists of multiple public database sources such as Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) (http://www.genome.jp/
kegg/), Gene Ontology (http://www.geneontology.org/), Pfam
(http://pfam.xfam.org/), and the GWAS Catalog (https://www.
ebi.ac.uk/gwas/). These sources are linked in the Library of
Knowledge Integration so that a user can provide a list of either
SNPs or genes and get the SNPs annotated by gene, the genes
annotated by group (pathway, protein family, etc.), and the lists
of genes that belong to specific groups. These annotations can
be used to filter gene sets into subsets prior to association analy-
ses. For example, in cataract susceptibility, Hall et al. (53) used
Biofilter to identify potential gene-gene interactions in the
eMERGE network. This same process could be used for G×E
analysis with a candidate gene list based on either the disease or
the environmental-factor candidates; the user would provide the
candidate gene list, and Biofilter would provide all of the other
genes that are linked to the genes in the user’s list based on the
Library of Knowledge Integration. Tools like Biofilter make
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performing candidate-pathway, or gene-set, approaches more
efficient because they integrate knowledge from multiple public
data sources and enable researchers to use all of the sources
simultaneously.
Because of their novelty and the limited number of applications
that have been developed so far, it is challenging to assess the rele-
vance of these approaches. Obviously, their performances rely
on the validity of the underlying statistical and biological assump-
tions, such as valid and correct biological/pathway knowledge.
For example, in the later candidate-based approach, substantial
gain in power might be achieved if G×E are indeed enriched in
outcome/exposure pathways, but might have decreased power
otherwise. Also, as in the case of marginal-effects testing of genes
and pathways, the potential success of these strategies lies in their
ability to cope with multiple causal genes whose effects might
be heterogeneous across populations. Focusing on single-variant
association signals, as in standardG×EGWAS screening, implic-
itly assumes the effects of each variant is large enough and homo-
geneous enough that it can be replicated across populations.
However, when effects are small, and variability due to other
uncontrolled risk factors is high, gene- and pathway-based
tests, which aggregate information, might be more efficient than
those using SNPs as the testing unit. Thus, it is anticipated that
these pathway-based approaches could increase power by magni-
tudes, assuming that the knowledge used is accurate. This is a crit-
ical assumption. Direct comparisons of the statistical power of the
different approaches are not possible at this time. However, as
more applications of these approaches are published, wewill learn
more about the gain in power through the use of these pathway-
based strategies.
FUTUREDIRECTIONSANDCONCLUSIONS
We have described several different biological considerations
that can be used to improve power and increaseflexibility in using
prior knowledge and/or multiple data types in G×E analyses. The
wealth of biological knowledge that has been discovered over
the past two decades is astonishing. It is clearly to our benefit to
include this knowledge; this is particularly important because it
can help us find biologically meaningful G×Es. Also, this knowl-
edge may be useful to help identify interactions with rare or low-
frequency variants thatmay have beenmissed previously.
An additional important consideration is that of replication
of the G×E effects. In genetics, replication of association has
become the gold standard (54). Here, to avoid an inflation of
false positives, the field looks for replication of the precise result
in multiple, independent data sets. This is an important strategy
under an assumption where we believe that one particular SNP
and one particular exposure measurement are important for the
disease of interest. However, if we start to consider gene-based
models or pathway models, what is the “model” that we need
to replicate? If we see several genes from a particular pathway
associating in a G×E with a particular trait of interest in one
data set and then 2 different genes from the same pathway asso-
ciating in a G×E in a second data set, is that replication? This
would not be a replication under the traditional definition (the
same independent variables combined in the same statistical
model with the same direction of effect). We need to consider
this apparent contradiction more carefully as we expand analy-
ses to accommodate gene-based or pathway-based approaches.
Our ability to integrate information from multi-omics ap-
proaches, the literature, and other public knowledge sources
provides tremendous power to deal with the challenges inherent
in big-data analyses. In the coming years, we expect to see more
G×E analyses incorporating biological knowledge–driven strat-
egies similar to those described here. These approaches will
continue to evolve and expand as we learn more about the
relationships between the genome and the exposome in the
architecture of complex traits.
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25. Çalışkan M, Baker SW, Gilad Y, et al. Host genetic variation
influences gene expression response to rhinovirus infection.
PLoS Genet. 2015;11(4):e1005111.
26. Alasoo K, Rodrigues J, Mukhopadhyay S, et al. Genetic effects
on chromatin accessibility foreshadow gene expression
changes in macrophage immune response. bioRxiv. (doi:10.
1101/102392).
27. Chun S, Casparino A, Patsopoulos NA, et al. Limited statistical
evidence for shared genetic effects of eQTLs and autoimmune-
disease-associated loci in three major immune-cell types. Nat
Genet. 2017;49(4):600–605.
28. Yao C, Joehanes R, Johnson AD, et al. Sex- and age-
interacting eQTLs in human complex diseases.HumMol
Genet. 2014;23(7):1947–1956.
29. Kukurba KR, Parsana P, Balliu B, et al. Impact of the X
chromosome and sex on regulatory variation.Genome Res.
2016;26(6):768–777.
Am J Epidemiol. 2017;186(7):771–777
776 Ritchie et al.
30. Knowles DA, Davis JR, Edgington H, et al. Allele-specific
expression reveals interactions between genetic variation and
environment.Nat Methods. 2017;14(7):699–702.
31. Zhernakova DV, Deelen P, Vermaat M, et al. Identification of
context-dependent expression quantitative trait loci in whole
blood. Nat Genet. 2017;49(1):139–145.
32. Teh AL, Pan H, Chen L, et al. The effect of genotype and in
utero environment on interindividual variation in neonate DNA
methylomes.Genome Res. 2014;24(7):1064–1074.
33. Galanter JM, Gignoux CR, Oh SS, et al. Differential
methylation between ethnic sub-groups reflects the effect of
genetic ancestry and environmental exposures. Elife. 2017;6:
e20532.
34. Mangravite LM, Engelhardt BE, MedinaMW, et al. A statin-
dependent QTL for GATM expression is associated with
statin-induced myopathy.Nature. 2013;502(7471):377–380.
35. Aschard H. A perspective on interaction effects in genetic
association studies.Genet Epidemiol. 2016;40(8):678–688.
36. LoveMI, Huber W, Anders S. Moderated estimation of fold
change and dispersion for RNA-seq data with DESeq2.
Genome Biol. 2014;15(12):550.
37. Stegle O, Parts L, Piipari M, et al. Using probabilistic
estimation of expression residuals (PEER) to obtain increased
power and interpretability of gene expression analyses.Nat
Protoc. 2012;7(3):500–507.
38. Mostafavi S, Battle A, Zhu X, et al. Normalizing RNA-
sequencing data by modeling hidden covariates with prior
knowledge. PLoS One. 2013;8(7):e68141.
39. Leek JT. svaseq: removing batch effects and other unwanted
noise from sequencing data. Nucleic Acids Res. 2014;42(21):
e161.
40. Moyerbrailean GA, Richards AL, Kurtz D, et al. High-
throughput allele-specific expression across 250 environmental
conditions.Genome Res. 2016;26(12):1627–1638.
41. Buil A, Brown AA, Lappalainen T, et al. Gene-gene and gene-
environment interactions detected by transcriptome sequence
analysis in twins. Nat Genet. 2015;47(1):88–91.
42. Wright FA, Sullivan PF, Brooks AI, et al. Heritability and
genomics of gene expression in peripheral blood.Nat Genet.
2014;46(5):430–437.
43. Thomas D. Gene–environment-wide association studies:
emerging approaches.Nat Rev Genet. 2010;11(4):259–272.
44. Subramanian A, Tamayo P, Mootha VK, et al. Gene set
enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad
Sci USA. 2005;102(43):15545–15550.
45. Wei S, Wang LE, McHughMK, et al. Genome-wide gene-
environment interaction analysis for asbestos exposure in
lung cancer susceptibility. Carcinogenesis. 2012;33(8):
1531–1537.
46. Parnell LD, Blokker BA, Dashti HS, et al. CardioGxE, a
catalog of gene-environment interactions for cardiometabolic
traits. BioData Min. 2014;7:21.
47. Rava M, Ahmed I, Demenais F, et al. Selection of genes for
gene-environment interaction studies: a candidate pathway-
based strategy using asthma as an example. Environ Health.
2013;12:56.
48. Huang T, Hu FB. Gene-environment interactions and obesity:
recent developments and future directions. BMCMed
Genomics. 2015;8(suppl 1):S2.
49. Tang H,Wei P, Duell EJ, et al. Axonal guidance signaling
pathway interacting with smoking in modifying the risk of
pancreatic cancer: a gene- and pathway-based interaction
analysis of GWAS data.Carcinogenesis. 2014;35(5):
1039–1045.
50. Biankin AV,Waddell N, Kassahn KS, et al. Pancreatic cancer
genomes reveal aberrations in axon guidance pathway genes.
Nature. 2012;491(7424):399–405.
51. BushWS, Dudek SM, Ritchie MD. Biofilter: a knowledge-
integration system for the multi-locus analysis of genome-wide
association studies. Pac Symp Biocomput. 2009;368–379.
52. Pendergrass SA, Frase A,Wallace J, et al. Genomic analyses
with Biofilter 2.0: knowledge driven filtering, annotation, and
model development. BioData Min. 2013;6(1):25.
53. Hall MA, Verma SS,Wallace J, et al. Biology-driven gene-
gene interaction analysis of age-related cataract in the
eMERGE network.Genet Epidemiol. 2015;39(5):376–384.
54. NCI-NHGRIWorking Group on Replication in Association
Studies, Chanock SJ, Manolio T, et al. Replicating genotype-
phenotype associations. Nature. 2007;447(7145):655–660.
Am J Epidemiol. 2017;186(7):771–777
Biological Knowledge for Gene-Environment Interactions 777
